J Clin Neurol. 2023 Nov;19(6):530-538. English.
Published online Jun 01, 2023.
Copyright © 2023 Korean Neurological Association
Original Article

Clinical Course and Recurrence in Transient Global Amnesia: A Study From the TEMPiS Telestroke Network

Shadi Taheri,a,b,* Nils Peters,a,b,c,* Annaelle Zietz,b,c Berthold Abel,a Gordian Hubert,d Filip Barinka,a,e Hanni Wiestler,d Irena Kovacic,e Ralf Linker,e Felix Schlachetzki,e and Roland Backhause,f
    • aStroke Center, Klinik Hirslanden, Zürich, Switzerland.
    • bUniversity of Basel, Basel, Switzerland.
    • cDepartment of Neurology and Stroke Center, University Hospital Basel, Basel, Switzerland.
    • dDepartment of Neurology, TEMPiS Telemedical Stroke Center, München Klinik Harlaching, Munich, Germany.
    • eDepartment of Neurology, University of Regensburg, TEMPiS Telemedical Stroke Center, Medbo Bezirksklinikum Regensburg, Regensburg, Germany.
    • fSwiss Clinical Neuroscience Institute, Zurich, Switzerland.
Received September 25, 2022; Revised November 17, 2022; Accepted March 07, 2023.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background and Purpose

While the clinical hallmarks of transient global amnesia (TGA) are well defined, its pathophysiological causes are poorly understood. Specifically, risk factors for recurrences are yet to be determined.

Methods

This retrospective study analyzed TGA cases diagnosed and treated within the TEMPiS telestroke network and a university stroke center in Germany. Demographic and clinical data were assessed and characteristics of TGA episodes were recorded, such as season of occurrence, trigger factors, duration, and concomitant symptoms. Follow-up of the potential recurrence of TGA was performed using a standardized questionnaire.

Results

Overall 109 patients were included (age 64±8 years [mean±SD], 59.6% female). The most common vascular risk factor was arterial hypertension (60.6%), and other concomitant conditions included migraine (11.9%), hypothyroidism (22.9%), and atrial fibrillation (4.6%). The most frequent concomitant clinical feature accompanying the TGA episode at admission was elevated blood pressure (48.6%). Nineteen patients experienced at least one recurrent TGA episode. Migraine and hypothyroidism were only observed in subjects with a single TGA episode without recurrence (migraine: 14.4% without recurrence vs. none in the recurrence group, p=0.02; hypothyroidism: 27.8% without recurrence vs. none in the recurrence group, p=0.009). In contrast, atrial fibrillation was more common in subjects with TGA recurrence (p<0.001).

Conclusions

Arterial hypertension is prevalent in TGA patients, with elevated blood pressure being the most-frequent concomitant condition. In our cohort, recurrence of TGA occurred in approximately one-fifth of patients. Concomitant conditions such as migraine, hypothyroidism, and atrial fibrillation occurred at different frequencies in the two groups.

Keywords
transient global amnesia; arterial hypertension; recurrent TGA; trigger factors; telemedical stroke network

INTRODUCTION

Transient global amnesia (TGA) is a clinical syndrome characterized by a sudden, reversible loss of anterograde and retrograde memory for up to around 24 hours.1, 2 New information cannot be memorized during the acute episode, which typically results in repetitive questions by the patients.3 The main clinical characteristic of TGA is that consciousness and procedural memory remain unaffected.1, 2 The clinical diagnosis of TGA is based on the criteria of Hodges and Warlow1, 2 and the exclusion of important differential diagnoses.4 TGA may be induced by external triggers such as cold water, physical exercise, or emotional stress, pain, or sexual activity, but may also occur spontaneously.3

The cause of TGA is still not well understood, and various potential pathomechanisms have been considered. Functional MRI has revealed the involvement of the hippocampal cornu ammonis 1 (CA1) region in amnestic episodes.5 This is consistent with the clinical syndrome but does not explain the detailed pathophysiology underlying it. One potential mechanism discussed is the mechanism of “cortical spreading depression,” which is also observed in migraine.6 Moreover, the susceptibility of CA1 neurons to stress factors suggests that excitotoxicity via mechanisms such as glutamine release could contribute.7, 8 Furthermore, vascular mechanisms such as focal ischemia in the hippocampus or venous congestion causing a transient intracranial hypertension are discussed as potential mechanisms, supported by the appearance of hyperintense hippocampal changes indicating diffusion restriction on diffusion-weighted imaging (DWI) MRI.9, 10

Given the acute onset of the TGA, symptoms may lead to an initial differential diagnosis of acute ischemic stroke; for example, an embolic stroke in the posterior cerebral artery territory. TGA potentially has the form of a “stroke mimic,” and affected subjects may therefore acutely present at a specialized emergency or stroke department. The Telemedical Project for Integrated Stroke Care (TEMPiS) performed in southeast Bavaria, Germany started as a pilot project in February 2003 and has emerged as the standard of care in rural southeastern Bavaria.11

This multicenter telemedical stroke support network provides diagnoses and/or therapeutic interventions to patients with acute neurological symptoms. Thus, patients with suspicion of acute stroke including “stroke mimics” such as TGA can be diagnosed in specialized stroke departments or in community hospitals with telemedical support provided by experienced neurologists when there is no on-site neurologist. Identifying the clinical factors (including concomitant vascular conditions) associated with TGA is important for patient counseling and for managing vascular risk factors and their relationship with TGA recurrence. However, knowledge on these aspects is currently limited, since the reported rates of TGA recurrence have varied widely from 3% to 26% depending on the follow-up durations in different studies.12 A recent published review described a recurrence rate of 13.5% in TGA patients, and discussed a possible relationship between recurrence and a history of migraine and/or depression.13

The aims of the present cohort study based on the multicenter TEMPiS network data were as follows: 1) to identify concomitant vascular risk factors as well as other preexisting diseases in subjects diagnosed with TGA, 2) to characterize concomitant cerebrovascular disease, including the presence of atherosclerotic large-vessel disease, 3) to characterize TGA episodes using clinical and MRI measures, and 4) to determine the frequencies of recurrences in TGA and identify potential factors associated with TGA recurrence.

METHODS

This retrospective analysis was applied to patients assessed by stroke experts of the TEMPiS telestroke network and patients who presented at the Department of Neurology and Stroke Center (University of Regensburg, medbo Bezirksklinikum Regensburg, Regensburg, Germany) due to acute neurological symptoms and were eventually diagnosed with TGA. We collected clinical data from the medical records of patients, with the diagnosis of TGA established by the involved neurologist (at the treating center or by telemedical support via TEMPIS) between 2009 and 2018. The study was approved by the ethics committee of the University of Regensburg (IRB No. 17-949-101).

TEMPiS network

The TEMPiS was established in Bavaria, Germany in 2003. The two stroke centers (Department of Neurology, München Klinik Harlaching and the Department of Neurology, University of Regensburg, medbo Bezirksklinikum) are the telemedical stroke centers that equally provide online support to the integrative treatment of acute stroke patients in up to 24 community hospitals. The effectiveness of telestroke networks in terms of providing acute stroke care including thrombolysis and improving stroke outcomes has been shown in numerous studies, but expertise also exists in areas such as intracerebral hemorrhage treatment, poststroke depression, and postoperative stroke.11, 14, 15, 16, 17

Inclusion criteria

The inclusion criteria were a clinical diagnosis of TGA using the Hodges and Warlow criteria,1, 2 with the exclusion of acute ischemic stroke based on DWI-MRI and/or CT in cases where imaging was performed. We assessed the diagnostic data available from the acute phase, including DWI-MRI and extracranial neurovascular ultrasonography results. Patients were contacted by the main study center at the Department of Neurology, University of Regensburg and asked to participate in the study and provide additional information using a standardized questionnaire, including information about TGA recurrence and overall comprising 15 questions on the index-event trigger factors, preexisting illnesses, medication, and recurrences during the follow-up duration and/or previous episodes (Supplementary Material in the online-only Data Supplement). Patients who consented to participate and returned the questionnaire were included in the study. Patients were interviewed via phone to obtain more details about the recurrence episode and to confirm the diagnosis based on medical records, if they were available.

Cohort and data collection

Overall 227 patients were identified with a diagnosis of TGA in the TEMPiS data set and in the inpatient data archive of the Department of Neurology in Regensburg. These patients were asked to participate in the study, and 113 of them agreed to participate and returned a completed questionnaire. These cases were re-evaluated in detail centrally based on the medical records for confirmation of the initial diagnosis of TGA. Three cases were excluded due to an overall unclear diagnosis, and another patient was excluded due to withdrawal of consent after their initial participation. Thus, 109 cases were finally included in our study.

The following clinical and demographic data were assessed in this study: age, sex, date/season of hospitalization, medical history (especially the presence of hypertension, diabetes, migraine, hypothyroidism, atrial fibrillation, hyperlipidemia, current or historical smoking, history of vascular disease, and family history of vascular disease), and medications at the time of acute admission (especially including antithrombotic medication such as an antiplatelet or oral anticoagulant). We further analyzed clinical features of TGA, potential concomitant symptoms (e.g., headache, nausea, or unspecific symptoms), and potential trigger factors of TGA (e.g., emotional/physical stressors or the Valsalva maneuver). If available, we assessed DWI-MRI and neurovascular ultrasonography results. In the DWI-MRI scans we searched for hyperintense, unilateral or bilateral lesions in the hippocampal area, and we also assessed the duration between symptom onset and MRI.18 Patients with an acute ischemic lesion in the hippocampus appearing as ischemic stroke were excluded from our cohort. The diagnosis of a relevant atherosclerotic stenosis was defined by NASCET criteria.

All data were saved while respecting data safety criteria, and the statistical analyses were performed based on coded data with patient identities obscured.

Statistical analyses

We first described our patient cohort and presented the numbers and proportions accordingly. We then compared demographic and clinical profiles as well as imaging characteristics between patients with and without TGA recurrence. We used the chi-square test for categorical variables, the t-test for continuous variables, and the Mann-Whitney U test for nonnormally distributed data. Statistical analyses were performed using IBM SPSS Statistics software (version 28; IBM Corp., Armonk, NY, USA).

RESULTS

Patient cohort and characteristics of TGA

The 109 patients were aged 64±8 years (mean±SD), and 65 (59.6%) of them were female.

The most common cardiovascular risk factor was arterial hypertension (n=66, 60.6%), with the other concomitant diseases including migraine (n=13, 11.9%), hypothyroidism (n=25, 22.9%), and atrial fibrillation (n=5, 4.6%). The median blood pressure on admission was 188/96 mm Hg. The detailed clinical and demographic characteristics of the cohort are presented in Table 1.

Table 1
Baseline characteristics of the total cohort (n=109)

Most subjects had no history of prior cerebro- or cardiovascular disease such as myocardial infarction or stroke (absent in n=101 [92.7%]). Data were missing for 1 patient (0.9%), and the remaining seven subjects comprised four (3.7%) with a history of myocardial infarction and three (2.8%) with a history of stroke. Overall 47 (43.1%) subjects reported a positive family history of vascular disease. Most subjects did not receive antithrombotic medication on admission (n=89, 81.7%).

Regarding season of occurrence, an increase in the colder months was observed, with most episodes occurring during autumn and winter (n=27 [24.8%] and n=37 [33.9%], respectively; Fig. 1).

Fig. 1
Seasonal distribution of transient global amnesia cases.

At least 1 possible trigger of the TGA was reported for 93 (85.3%) subjects, no special trigger was reported for 15 (13.8%) subjects, and data were not available for 1 patient (0.9%). The most-frequent reported trigger factors of TGA were emotional stress (n=35, 32.1%) and physical exercise (n=47, 43.1%). TGA episodes lasted less than 60 minutes in 14 subjects (12.8%), 1–12 hours in 26 subjects (23.9%), and 12–24 hours in the majority of cases (n=62, 56.9%). Information on duration was not available for seven subjects (6.4%). A duration of more than 24 hours was not reported. Concomitant clinical features that accompanied the TGA episode at admission included elevated blood pressure (n=53, 48.6%), headache (n=8, 7.3%), and nausea (n=8, 7.3%).

Imaging characteristics and concomitant cerebrovascular disease

Most patients (n=78, 71.6%) underwent brain MRI at admission, including DWI to rule out acute ischemic stroke and to assess hippocampal DWI lesions indicative of TGA. Overall MRI was performed at a median of 2 days after symptom onset. Among the patients (n=31, 28.4%) without MRI data, CT was performed in 12 patients (11.0%) to rule out an acute intracranial pathology. In 4 patients (3.6%) the diagnosis was made clinically without performing neuroimaging. Imaging data were not available in the other cases (n=15, 13.8%). Among the patients who underwent MRI, the results were missing for 1 patient.

Among patients with available MRI data, 31 patients (39.7%) showed a typical DWI-positive MRI lesion in the hippocampus: on the left side in 12 (38.7%), on the right side in 13 (41.9%), and bilaterally in 6 (19.4%).

Seventy-eight patients (71.6%) underwent ultrasonography of the extracranial and intracranial arteries supplying the brain (including the carotid artery), among whom atherosclerosis was characterized as mild in 28 patients (35.9%) and moderate in 17 patients (21.8%). A hemodynamically relevant atherosclerotic internal carotid artery stenosis was present in 13 patients (16.7%), while 14 (17.9%) had elongative arteriopathy, 1 (1.2%) had dilatative arteriopathy, and 6 (7.6%) had mixed arteriopathies.

An overall analysis of intracranial vessels was performed using time-of-flight MRI angiography or ultrasonography. CT angiography was performed in 3 patients who underwent CT. Data on intracranial vessels were not available for 11 patients.

TGA recurrence

Table 2 compares characteristics between subgroups of patients with a single TGA episode (s-TGA) and patients with recurrent TGA (r-TGA). The median follow-up durations were 34 and 48 months in subjects with s-TGA and r-TGA, respectively.

Table 2
Comparison of subjects with and without recurrence of TGA

Overall 90 patients experienced s-TGA, and they were aged 63.3±11.2 years and included 55 (61.1%) females, while 19 patients experienced r-TGA, who were aged 68.8±6.1 years at the time point of the index event. Thus, the r-TGA group was significantly older than the s-TGA group (p=0.046).

Among the 19 patients in the r-TGA group, 6 (31.6%) reported TGA recurrence at follow-up after the index event, 13 (68.4%) had previously experienced TGA, and 6 had experienced more than 2 TGA episodes.

There was no significant difference between the s-TGA and r-TGA groups regarding sex, concomitant vascular risk factors, duration of the TGA episode, or the antithrombotic medication at admission (p=0.119). A trigger for TGA could be identified in 86.6% of the subjects in the s-TGA group and in 84.2% of those in the r-TGA group, with no significant difference (p=0.868). There was also no significant intergroup difference regarding the presence of a hippocampal DWI lesion in MRI. The presence of large-vessel disease in ultrasonography also did not differ significantly between the s-TGA and r-TGA groups (p=0.598).

Regarding preexisting illnesses, there were some differences observed between the groups: migraine was significantly more frequent in the s-TGA group (n=13 [14.4%] vs. none in r-TGA, p=0.02), as was hypothyroidism (n=25 [27.8%] vs. none in r-TGA, p=0.009). In contrast, atrial fibrillation was more common in the r-TGA group (1 patient in the s-TGA group [1.1%] and 4 patients in the r-TGA group [21.1%], p<0.001). We did not observe an increased rate of DWI lesions in the subjects with atrial fibrillation.

DISCUSSION

In this study we made the following observations: 1) most TGA episodes occurred during autumn and winter, and most patients reported a potential trigger, 2) approximately 40% of the patients who underwent DWI-MRI showed characteristic DWI-positive lesions in the hippocampi, and arteriosclerotic large-vessel disease was present in more than half of the patients investigated by neurovascular ultrasonography, 3) arterial hypertension was frequently observed in patients with TGA, while most patients did not have a history of cerebro- or cardiovascular disease, 4) approximately half of the patients were hypertensive at admission during the acute TGA, and 5) approximately one-fifth of the patients experienced recurrence of TGA, and at the time point of the index event these patients were older and more frequently had atrial fibrillation, while other concomitant diseases (migraine and hypothyroidism) were more common in subjects without recurrence.

TGA patients are generally aged between 50 and 70 years, but TGA may also occur in both younger and older subjects.12 We did not observe any differences regarding the occurrence of TGA between males and females, which is consistent with the findings of some previous studies, while other studies found a female predominance in TGA occurrence.12, 19 Females seem to experience TGA more often after an emotional trigger, while in males physical stressors are present more often.12, 19

Emotional stress and physical activity are frequently reported to be the most common trigger factors of TGA, which is consistent with our results.3, 4, 20 The underlying reasons remain unclear, but changes in body homeostasis and in emotional states as well as individual factors have been discussed.3, 12

Seasonal variations in TGA cases have been reported previously.21, 22 We similarly found a predominance of TGA in the colder months (autumn/winter). Akkawi et al.22 found an association between low ambient temperature and the occurrence of TGA, which is consistent with our results.

Regarding neuroimaging, MRI was performed in two-thirds of the clinical TGA cases, and approximately 40% of these subjects had an acute DWI lesion in the hippocampus. The reported rate at which DWI hyperintensity is found in TGA patients has varied markedly among studies (12%–86%) depending on the sensitivity and slice thickness of the scans.18 The timing of MRI is also relevant, since the detection rate increases if scans are performed approximately 48 hours after symptom onset.18, 23 In our cohort, MRI scans were mostly performed within 3 days. Sedlaczek et al.23 detected a small, punctate DWI lesion in more than 80% of cases, mostly on the left side (approximately 60% of cases), with the remaining 20% of cases showing this on the right side or bilaterally. They similarly found that lesions were rarely visible during the hyperacute phase, while after 48 hours the detection rate increased.23

Approximately 50% of our subjects showed elevated blood pressure on admission, and approximately 60% had a diagnosis of arterial hypertension at the time of the clinical onset. The pathophysiological cause of this remains unclear. Melo et al.24 found in a case-control study in 1992 that hypertension and migraine were significantly more common in TGA patients than in normal controls. More recently, Rogalewski et al.25 implicated a strong association between acute hypertensive peaks and TGA, especially in patients not adapted to chronic hypertension. A vascular cause of the disease has therefore been hypothesized. It remains unclear if the hypertensive episode triggers TGA itself or if hypertension is a reaction to the situation caused by the amnesia, since TGA patients may be aware of their situation, potentially leading to a restlessness, which could be accompanied by elevated blood pressure. Further studies of pathophysiological relations are required to explain this correlation. Overall, the association of elevated blood pressure with TGA is clinically relevant for patient management and could potentially lead to the first diagnosis of arterial hypertension in affected subjects. However, arterial hypertension and elevated blood pressure were not associated with TGA recurrence.

In this study we further aimed to understand the frequencies of recurrences and identify the potential associated risk factors. In our cohort migraine was not associated with TGA recurrence, which contrasts with the findings of other studies, especially those of Liampas et al.,7 Morris et al.,26 Alessandro et al.27 In our study the presence of preexisting or ongoing migraine was assessed directly in the questionnaires, with answers from the patients being cross-checked with the hospitalization medical records during the TGA attack. This procedure increased the reliability of detecting migraine in the TGA patients. In our cohort the prevalence of migraine in patients without recurrence (14%) was slightly lower than that of 20% found by Morris et al.,26 while we observed no patient with a history of migraine in our recurrence group, which contrasts markedly with the rate of 36.4% found by those authors in patients with recurrence. The reasons for these contradictory findings regarding the association between migraine and TGA, and especially TGA recurrence, remain unclear and so should be investigated in further studies.

In our cohort, hypothyroidism was also more common in the s-TGA group, with no patient in the r-TGA group having hypothyroidism as a concomitant disease. Related studies are scarce, although the meta-analysis of Liampas et al.13 and the study of Alessandro et al.27 found no association between hypothyroidism and TGA either in patients with or without recurrence. Overall, the role of thyroid function in the context of TGA remains to be resolved.

We observed a higher rate of atrial fibrillation in the r-TGA group than in the s-TGA group, which was not found in those two previous studies.13, 27 Alessandro et al.27 found atrial fibrillation in 4% of their total cohort, with all cases in the nonrecurrent-TGA group. Thus, the potential role of atrial fibrillation in the context of TGA recurrence has yet to be clarified. Potential age-related vascular mechanisms related to atrial fibrillation may be shared by TGA, but given the small number of subjects, our findings need to be interpreted with caution. Also, the r-TGA group was older at the time point of the index event.

Another study commonly found atrial fibrillation in TGA patients with a new DWI hyperintensity in MRI, leading to the suggestion of an increased risk of subsequent stroke, while in our cohort there were no differences in neuroimaging results between patients with and without recurrence.28

Oliveira et al.29 recently performed a retrospective investigation of risk factors predicting recurrence in TGA. Those authors observed an overall high rate of TGA recurrence of 27.1%, which was associated with female sex, depression, shorter episode, and a hippocampal hyperintensity on brain MRI. In contrast, arterial hypertension was not related to recurrence, but was overall prevalent in the reported cohort. This is consistent with the findings of our slightly larger study, which also extends the findings of Oliveira et al.29 by identifying other concomitant conditions associated with TGA recurrence.

Our study has some limitations that need to be discussed. The study had a retrospective design and only about 50% of the subjects identified and contacted agreed to participate and returned the questionnaire, which reduced the size of the total cohort. Also, some detailed data were not available for all of the included subjects; however, as stated in the Results section, the frequency of missing data was overall low. Our cohort was smaller than that in the study of Morris et al.26 on factors associated with the risk of recurrent TGA. However, our study included a thoroughly assessed and well-described cohort from a well-established specialized neurovascular network, which extends the previously reported findings especially with respect to vascular comorbidities and risk factors. The follow-up duration differed somewhat in the two groups, being slightly longer in the r-TGA group. This was especially due to those subjects who reported a previous diagnosis of a TGA episode, while the six subjects with r-TGA during follow-up showed a shorter median follow-up duration of 16 months. While this difference in follow-up duration might have influenced the subject categorization, these differences were only moderate. Finally, while not every subject underwent MRI or ultrasonography, more than 70% received both imaging modalities, and so these subgroups can be regarded as representative.

Our study has several strengths. The total cohort was relatively large, comparable to those in previous studies,6, 7, 20 and was well characterized. The diagnosis of TGA was established by experienced neurologists within a large stroke network, and a re-evaluation of individual diagnoses was performed for this study. Sending standardized questionnaires to patients made a median follow-up of 32.5 months possible, allowing a longitudinal course over more than 2 years with analyses of TGA recurrences and potential risk factors related to recurrence.

In conclusion, a recurrence rate of 17% was observed in our cohort, and high rates of arterial hypertension and elevated blood pressure on admission in patients with TGA were observed. The awareness of this is of clinical relevance, suggesting the need for thorough blood pressure monitoring in TGA subjects. Regarding recurrences, migraine and hypothyroidism were more common in subjects with s-TGA, while higher age and atrial fibrillation were more common in patients with r-TGA. The pathophysiological mechanisms underlying our findings remain unclear and so further studies are needed.

Supplementary Materials

The online-only Data Supplement is available with this article at https://doi.org/10.3988/jcn.2022.0368.

SUPPLEMENTARY MATERIAL

Click here to view.(23K, pdf)

Notes

Author Contributions:

  • Conceptualization: Shadi Taheri, Nils Peters, Roland Backhaus.

  • Data curation: Shadi Taheri.

  • Formal analysis: Shadi Taheri, Nils Peters, Annaelle Zietz, Berthold Abel.

  • Investigation: Shadi Taheri, Nils Peters, Roland Backhaus.

  • Methodology: Shadi Taheri, Nils Peters, Roland Backhaus.

  • Project administration: Shadi Taheri, Nils Peters, Roland Backhaus.

  • Resources: Shadi Taheri, Roland Backhaus.

  • Software: Shadi Taheri, Annaelle Zietz, Berthold Abel.

  • Supervision: Nils Peters, Roland Backhaus.

  • Validation: Shadi Taheri, Nils Peters, Gordian Hubert, Filip Barinka, Hanni Wiestler, Irena Kovacic, Ralf Linker, Felix Schlachetzki, Roland Backhaus.

  • Visualization: Shadi Taheri, Nils Peters, Berthold Abel.

  • Writing—original draft: Shadi Taheri, Nils Peters, Roland Backhaus.

  • Writing—review & editing: Shadi Taheri, Nils Peters, Gordian Hubert, Filip Barinka, Hanni Wiestler, Irena Kovacic, Ralf Linker, Felix Schlachetzki, Roland Backhaus.

Conflicts of Interest:The authors have no potential conflicts of interest to disclose.

Funding Statement:None

Availability of Data and Material

The datasets generated or analyzed during the study are available from the corresponding author on reasonable request.

References

    1. Hodges JR, Warlow CP. Syndromes of transient amnesia: towards a classification. A study of 153 cases. J Neurol Neurosurg Psychiatry 1990;53:834–843.
    1. Hodges JR, Warlow CP. The aetiology of transient global amnesia. A case-control study of 114 cases with prospective follow-up. Brain 1990;113:639–657.
    1. Bartsch T, Deuschl G. Transient global amnesia: functional anatomy and clinical implications. Lancet Neurol 2010;9:205–214.
    1. Taheri S, Peters N. [Memory loss - a case of sudden amnesia]. Praxis (Bern 1994) 2022;111:358–361.
      German.
    1. He S, Ye Z, Yang Q, Lin J, Chen X, Chen Z, et al. Transient global amnesia: risk factors, imaging features, and prognosis. Neuropsychiatr Dis Treat 2021;17:1611–1619.
    1. Zorzon M, Antonutti L, Masè G, Biasutti E, Vitrani B, Cazzato G. Transient global amnesia and transient ischemic attack. Natural history, vascular risk factors, and associated conditions. Stroke 1995;26:1536–1542.
    1. Liampas I, Siouras AS, Siokas V, Tsouris Z, Rikos D, Brotis A, et al. Migraine in transient global amnesia: a meta-analysis of observational studies. J Neurol 2022;269:184–196.
    1. Ding X, Peng D. Transient global amnesia: an electrophysiological disorder based on cortical spreading depression-transient global amnesia model. Front Hum Neurosci 2020;14:602496
    1. Mathew NT, Meyer JS. Pathogenesis and natural history of transient global amnesia. Stroke 1974;5:303–311.
    1. Schreiber SJ, Doepp F, Klingebiel R, Valdueza JM. Internal jugular vein valve incompetence and intracranial venous anatomy in transient global amnesia. J Neurol Neurosurg Psychiatry 2005;76:509–513.
    1. Audebert HJ, Schenkel J, Heuschmann PU, Bogdahn U, Haberl RL. Telemedic Pilot Project for Integrative Stroke Care Group. Effects of the implementation of a telemedical stroke network: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria, Germany. Lancet Neurol 2006;5:742–748.
    1. Quinette P, Guillery-Girard B, Dayan J, de la Sayette V, Marquis S, Viader F, et al. What does transient global amnesia really mean? Review of the literature and thorough study of 142 cases. Brain 2006;129:1640–1658.
    1. Liampas I, Raptopoulou M, Mpourlios S, Siokas V, Tsouris Z, Aloizou AM, et al. Factors associated with recurrent transient global amnesia: systematic review and pathophysiological insights. Rev Neurosci 2021;32:751–765.
    1. Audebert HJ, Schultes K, Tietz V, Heuschmann PU, Bogdahn U, Haberl RL, et al. Long-term effects of specialized stroke care with telemedicine support in community hospitals on behalf of the Telemedical Project for Integrative Stroke Care (TEMPiS). Stroke 2009;40:902–908.
    1. Voelkel N, Hubert ND, Backhaus R, Haberl RL, Hubert GJ. Thrombolysis in postoperative stroke. Stroke 2017;48:3034–3039.
    1. Backhaus R, Schlachetzki F, Rackl W, Baldaranov D, Leitzmann M, Hubert GJ, et al. Intracranial hemorrhage: frequency, location, and risk factors identified in a TeleStroke network. Neuroreport 2015;26:81–87.
    1. Schwab-Malek S, Vatankhah B, Bogdahn U, Horn M, Audebert HJ. Depressive symptoms and quality of life after thrombolysis in stroke: the TEMPiS study. J Neurol 2010;257:1848–1854.
    1. Scheel M, Malkowsky C, Klingebiel R, Schreiber SJ, Bohner G. Magnetic resonance imaging in transient global amnesia: lessons learned from 198 cases. Clin Neuroradiol 2012;22:335–340.
    1. Hoyer C, Ebert A, Sandikci V, Platten M, Szabo K. Sex-related differences in stressful events precipitating transient global amnesia - A retrospective observational study. J Neurol Sci 2021;425:117464
    1. Tynas R, Panegyres PK. Factors determining recurrence in transient global amnesia. BMC Neurol 2020;20:83
    1. Keret O, Lev N, Shochat T, Steiner I. Seasonal changes in the incidence of transient global amnesia. J Clin Neurol 2016;12:403–406.
    1. Akkawi NM, Agosti C, Grassi M, Borroni B, Pezzini A, Vignolo LA, et al. Weather conditions and transient global amnesia. A six-year study. J Neurol 2006;253:194–198.
    1. Sedlaczek O, Hirsch JG, Grips E, Peters CN, Gass A, Wöhrle J, et al. Detection of delayed focal MR changes in the lateral hippocampus in transient global amnesia. Neurology 2004;62:2165–2170.
    1. Melo TP, Ferro JM, Ferro H. Transient global amnesia. A case control study. Brain 1992;115:261–270.
    1. Rogalewski A, Beyer A, Friedrich A, Plümer J, Zuhorn F, Greeve I, et al. Transient global amnesia (TGA): influence of acute hypertension in patients not adapted to chronic hypertension. Front Neurol 2021;12:666632
    1. Morris KA, Rabinstein AA, Young NP. Factors associated with risk of recurrent transient global amnesia. JAMA Neurol 2020;77:1551–1558.
    1. Alessandro L, Calandri IL, Suarez MF, Heredia ML, Chaves H, Allegri RF, et al. Transient global amnesia: clinical features and prognostic factors suggesting recurrence. Arq Neuropsiquiatr 2019;77:3–9.
    1. Simaan N, Honig A, Filioglo A, Jeremy M, Leker RR. The significance of atrial fibrillation in patients with transient global amnesia. Front Neurol 2022;13:830727
    1. Oliveira R, Teodoro T, Marques IB. Risk factors predicting recurrence of transient global amnesia. Neurol Sci 2021;42:2039–2043.

Metrics
Share
Figures

1 / 1

Tables

1 / 2

PERMALINK